{{Rsnum
|rsid=3756450
|Chromosome=5
|position=1448033
|Orientation=minus
|GMAF=0.3007
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 23.9 | 73.5
| HCB | 17.6 | 52.9 | 29.4
| JPT | 26.5 | 51.3 | 22.1
| YRI | 19.3 | 45.5 | 35.2
| ASW | 21.1 | 47.4 | 31.6
| CHB | 17.6 | 52.9 | 29.4
| CHD | 19.3 | 52.3 | 28.4
| GIH | 18.8 | 43.6 | 37.6
| LWK | 10.0 | 52.7 | 37.3
| MEX | 15.5 | 43.1 | 41.4
| MKK | 5.1 | 37.8 | 57.1
| TSI | 1.0 | 14.7 | 84.3
| HapMapRevision=28
}}{{PMID|18045777|OA=1
}} [[schizophrenia]] p = 0.035

{{PMID Auto
|PMID=20091113
|Title=Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers
}}
{{PMID Auto
|PMID=19273584
|Title=Functional analysis of upstream common polymorphisms of the dopamine transporter gene
|OA=1
}}

{{PMID Auto
|PMID=18330705
|Title=Physiogenomic analysis of localized FMRI brain activity in schizophrenia.
|OA=1
}}

{{PMID Auto
|PMID=19673036
|Title=Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}